Treace Medical Concepts, Inc. (TMCI)
NASDAQ · Healthcare
Treace Medical Concepts, Inc. annual/quarterly shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Treace Medical Concepts, Inc. shareholder equity for the quarter ending December 31, 2025 were 87.3M, a 22.64% decrease year-over-year.
- Treace Medical Concepts, Inc. shareholder equity for 2025 were 87.3M, a 22.64% decrease from 2024.
- Treace Medical Concepts, Inc. shareholder equity for 2024 were 112.9M, a 18.16% decrease from 2023.
- Treace Medical Concepts, Inc. shareholder equity for 2023 were 137.9M, a 127.89% increase from 2022.
- Treace Medical Concepts, Inc. shareholder equity for 2022 were 60.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Treace Medical Concepts, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $87 |
| 2024 | $113 |
| 2023 | $138 |
| 2022 | $61 |
| 2021 | $93 |
| 2020 | $1 |
| Treace Medical Concepts, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $87 |
| 2024-12-31 | $113 |
| 2023-12-31 | $138 |
| 2022-12-31 | $61 |
| 2021-12-31 | $93 |
| 2020-12-31 | $1 |
Treace Medical Concepts, Inc. Shareholder Equity — FAQ
Treace Medical Concepts, Inc. (TMCI) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TMCI's shareholder equity history?
The chart and table above show Treace Medical Concepts, Inc.'s shareholder equity by year and by quarter, including the growth rate.